Cargando…
DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling
The cell fate determination factor Dachshund (DACH1) functions as a novel suppressor in the progression of various neoplasms. Previous study has suggested that hypermethylation of promoter region was responsible for the reduction of DACH1 expression in hepatocellular carcinoma (HCC), and associated...
Autores principales: | Liu, Yu, Zhou, Rong, Yuan, Xun, Han, Na, Zhou, Si, Xu, Hanxiao, Guo, Mingzhou, Yu, Shiying, Zhang, Cuntai, Yin, Tiejun, Wu, Kongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496171/ https://www.ncbi.nlm.nih.gov/pubmed/25940701 |
Ejemplares similares
-
DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling
por: Han, Na, et al.
Publicado: (2015) -
DACH1 suppresses breast cancer as a negative regulator of CD44
por: Xu, Hanxiao, et al.
Publicado: (2017) -
DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells
por: Chu, Qian, et al.
Publicado: (2014) -
Endogenous Dach1 in cancer
por: Wu, Kongming, et al.
Publicado: (2015) -
DACH1 inhibits glioma invasion and tumor growth via the Wnt/catenin pathway
por: Wang, Jing, et al.
Publicado: (2018)